Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
June 11, 2018
Neovasc Announces Appointment of Steve Rubin as Chairman of the Board and General Update
VANCOUVER, June 11, 2018 /PRNewswire/ - Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral ...
June 11, 2018
Achaogen Highlights Multiple Plazomicin Presentations at ASM Microbe 2018 Annual Meeting
SOUTH SAN FRANCISCO, Calif., June 11, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (AKAO), a late-stage biopharmaceutical company developing innovative antibacterials addressing multi-drug resistant (MDR) gram-negative ...
June 11, 2018
INVENTIVA to Present at the 2018 JMP Securities Life Sciences Conference
Daix (France), June 11, 2018 - Inventiva S.A. ("Inventiva" or the "Company"), a biopharmaceutical company developing innovative therapies in nonalcoholic steatohepatitis (NASH), systemic sclerosis (SSc) ...
June 11, 2018
Aimmune Therapeutics Appoints Dr. Jayson Dallas as CEO
BRISBANE, Calif.--(BUSINESS WIRE)--Aimmune Therapeutics, Inc. (AIMT), a biopharmaceutical company developing treatments for potentially life-threatening food allergies, today announced the appointment of Jayson Dallas, M.D., as ...
June 11, 2018
Pfenex and Alvogen Enter into U.S. Agreement for Commercialization of PF708, a Therapeutic Equivalent Candidate to Forteo®
SAN DIEGO, June 11, 2018 (GLOBE NEWSWIRE) -- Pfenex (NYSE American:PFNX) and Alvogen today announced entering into an agreement granting Alvogen exclusive rights to commercialize ...
June 8, 2018
BioTime Announces Submission of Draft Registration Statement for a Proposed Distribution of Its AgeX Shares
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on degenerative diseases, announced that a draft registration statement on Form 10 was ...
June 8, 2018
Zealand Pharma achieves milestone in first Phase 3 trial with dasiglucagon for the treatment of severe hypoglycemia in diabetes
Copenhagen, 8 June, 2018 - Zealand Pharma A/S ("Zealand") announces that the primary and key secondary objectives of the first multinational Phase 3 clinical trial of ...
June 8, 2018
Albireo Elects Anne Klibanski and Stephanie Okey to Board of Directors
BOSTON, June 08, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (ALBO), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced ...
June 8, 2018
ADMA Biologics Announces Pricing of Public Offering of Common Stock
RAMSEY, N.J. and BOCA RATON, Fla., June 08, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (ADMA) (“ADMA” or the “Company”) announced today the pricing of ...
June 8, 2018
Oncobiologics Closes Second Tranche of $15 Million Private Placement
CRANBURY, N.J., June 08, 2018 (GLOBE NEWSWIRE) -- Oncobiologics, Inc. (ONS) (the “Company”) today announced that it has closed on the second, and final, tranche ...
June 7, 2018
Lipocine Announces Dosing in Ambulatory Blood Pressure Study for TLANDO™
SALT LAKE CITY, June 7, 2018 /PRNewswire/ -- Lipocine Inc. (LPCN), a specialty pharmaceutical company, today announced the dosing of the first subject in the ambulatory ...
June 7, 2018
Brainsway and Cohen Veterans Bioscience Announce Biomarker Research Collaboration in Post Traumatic Stress Disorder
HACKENSACK, N.J., June 07, 2018 (GLOBE NEWSWIRE) --  Brainsway Ltd. (BRIN.TA), a leader in the advanced non-invasive treatment of brain disorders, and Cohen Veterans Bioscience, ...
June 7, 2018
MannKind Successfully Completes Phase 1 Trial of Treprostinil Technosphere for Pulmonary Arterial Hypertension Advancing Development to Next Phase
WESTLAKE VILLAGE, Calif., June 07, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (MNKD) today announced that it has completed a Phase 1 clinical study of Treprostinil ...
June 7, 2018
Paratek Demonstrates Breadth of Omadacycline Clinical and Microbiological Data at ASM Microbe 2018
BOSTON, June 07, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (PRTK) announced today that data from its omadacycline clinical and microbiology programs will be presented ...
June 7, 2018
ADMA Biologics Announces Proposed Public Offering of Common Stock
RAMSEY, N.J. and BOCA RATON, Fla., June 07, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (ADMA) (“ADMA” or the “Company”) announced today that it has ...
June 7, 2018
Inspire Medical Systems, Inc. Reports First Quarter 2018 Financial Results
MINNEAPOLIS, June 07, 2018 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (INSP) ("Inspire”), a medical technology company focused on the development and commercialization of innovative ...
June 7, 2018
AIT Therapeutics Announces Change to Fiscal Year End and Financial Results Conference Call and Webcast for the Three Months Ended March 31, 2018
NEW YORK, June 07, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics Inc. (AITB), a clinical-stage biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the ...
June 7, 2018
EDAP TMS SA : EDAP Announces FDA Clearance for Focal One®
AUSTIN, TX, LYON, FRANCE -- JUNE 7, 2018 -- EDAP TMS SA (EDAP) ("the Company"), the global leader in therapeutic ultrasound, today announced that it ...
June 6, 2018
VBL Therapeutics Presents Positive Data on its MOSPD2 Platform Technology in Oncology and Inflammation at BIO 2018
TEL AVIV, Israel, June 05, 2018 (GLOBE NEWSWIRE) -- VBL Therapeutics (VBLT) today presented data on its novel MOSPD2 program in oncology and inflammation at the ...
June 6, 2018
Aptose Biosciences Announces Results of Annual Meeting of Shareholders
SAN DIEGO and TORONTO, June 05, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (APTO) (APS.TO), a clinical-stage company developing highly differentiated ...
Page 44 of 128